Showing 1‐6 of 6
results per page
technology
3D bioreactor manufacturing for cell therapies
Our allogeneic 3D process has been developed based on our extensive experience from handling a variety of bioreactors and cell lines to help you overcome the challenge of scale-up in allogeneic cell therapy.
technology
Therapeak™ Cell and Gene Therapy Media
Quality and safety are crucial to allow reliable results in clinical processes and ultimately, protect patients’ lives. We are dedicated to providing high quality cell and gene therapy products for global customers via our TheraPEAK™ Line of media and rea...
technology
Cocoon® Platform
Our proprietary Cocoon® Platform automates the production of autologous cell therapies, with the goal to overcome the challenges of cost, efficiency and variability.
technology
Exosomes development and manufacturing
Exosomes are small membrane vesicles that are secreted by a multitude of cell types, which play a role in cell to cell communication. They can serve as clinically valuable tools for early diagnosis, prognosis and potentially targeted treatment.
technology
iPSC manufacturing expertise
iPSC manufacturing systems enable scalable production of iPSCs in a cGMP setting, helping you develop and commercialize new therapies.
technology
Nucleofector™ Products
Nucleofector™ Products for efficient non-viral modification of primary cells, enabling generation of iPSC or CAR-T cells, or CRISPR-mediated engineering.